Additionally, it was found that genetic ablation of CD73, a surface ecto-5’-nucleotidase that converts adenosine monophosphate (AMP) to immunosuppressive adenosine, lowers GM-CSF in the tumor microenvironment thereby preventing MDSC development and improving CD4+ and CD8+ effector T cell responses (154). This evidence concerns the gene CD8A and neoplasm.